HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub
HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub 16 February 2021 | News Photo Credit: HKSTP AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation programme to support biomedical startups in their mission to develop integrated oncology solutions to accelerate innovation in oncology, foster local biomedical technologies and enhance Hong Kong’s status as a leading biomedical innovation hub. In the last decade, malignant cancerous tumours have been the number ...